D. Lockner

Comparison of Once-Daily Subcutaneous Fragmin® with Continuous Intravenous Unfractionated Heparin in the Treatment of Deep Vein Thrombosis

Per Lindmarker, Margareta Holmström, S. Granqvist et al. · Thrombosis and Haemostasis · 1994 · 212 citations

Deep Vein Thrombosis, Consecutive Patients, Thrombosis +18

A Comparison Between Low Molecular Weight Heparin (KABI 2165) and Standard Heparin in the Intravenous Treatment of Deep Venous Thrombosis

Göran Bratt, E. Törnebohm, S. Granqvist et al. · Thrombosis and Haemostasis · 1985 · 158 citations

Two Daily Subcutaneous Injections of Fragmin as Compared with Intravenous Standard Heparin in the Treatment of Deep Venous Thrombosis (DVT)

Göran Bratt, W. Åberg, Margareta Johansson et al. · Thrombosis and Haemostasis · 1990 · 150 citations

Thrombosis, Deep Venous Thrombosis, Venous Disease +15

Hypersensitive reactions and antibody formation during L-asparaginase treatment of children and adults with acute leukemia

D. Killander, A Dohlwitz, L. Engstedt et al. · Cancer · 1976 · 145 citations · Full text

Hypersensitive Reactions, Autoimmune Disease, Allergy +13

Low molecular weight heparin (KABI 2165, Fragmin): pharmacokinetics after intravenous and subcutaneous administration in human volunteers

Göran Bratt, E. Törnebohm, L. Widlund et al. · Thrombosis Research · 1986 · 119 citations

Thrombosis, Kabi 2165, Medicine +10